Translate Bio, Inc. Made Big Gain
Tue, Aug 03, 2021 at 05:30 PM
Translate Bio, Inc. (TBIO:NASDAQ) jumped higher at $37.67, representing a gain of 29.2%. The stock appeared on our News Catalysts scanner on Tue, Aug 03, 2021 at 04:59 PM in the 'MISCELLANEOUS' category. From Mon, Jul 19, 2021, the stock recorded 50.00% Up Days and 54.55% Green Days
The share price of the company has been moving sideways in recent weeks.
About Translate Bio, Inc. (TBIO:NASDAQ)
Translate Bio Inc is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, for the treatment of cystic fibrosis (CF) and MRT5201, for the treatment of ornithine transcarbamylase (OTC) deficiency.
Top 10 Gainers:
- China XD Plastics Company Limited (CXDC:NASDAQ), 152.65%
- Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ), 68.06%
- FLGC (FLGC:NASDAQ), 62.53%
- Wilhelmina International, Inc. (WHLM:NASDAQ), 40.46%
- Translate Bio, Inc. (TBIO:NASDAQ), 29.23%
- Hollysys Automation Technologies Ltd. (HOLI:NASDAQ), 28.19%
- AeroCentury Corp. (ACY:NYSEMKT), 27.68%
- Applied DNA Sciences, Inc. (APDN:NASDAQ), 25.41%
- HOOD (HOOD:NASDAQ), 24.2%
- Harmonic Inc. (HLIT:NASDAQ), 23.03%